Evidence map›Paper›PMID 36998292›Full record

ArticleAnnals of gastroenterological surgery2023

Have advances in medical therapy for ulcerative colitis impacted surgical treatment?

Ryuichi Kuwahara, Hiroki Ikeuchi, Yuki Horio, Tomohiro Minagawa, Kurando Kusunoki, Motoi Uchino

Open access · goldFull text read
In one paragraph

Article in Annals of gastroenterological surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ryuichi KuwaharaDivision of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Japan.ORCID https://orcid.org/0000-0001-7599-6330
Hiroki IkeuchiDivision of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Japan.ORCID https://orcid.org/0000-0001-9144-5782
Yuki HorioDivision of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Japan.
Tomohiro MinagawaDivision of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Japan.
Kurando KusunokiDivision of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Japan.
Motoi UchinoDivision of Inflammatory Bowel Disease Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Japan.ORCID https://orcid.org/0000-0002-2934-1680
Hyogo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: The purpose of this study was to examine how the clinical characteristics, indications for surgery, and postoperative course of ulcerative colitis (UC) surgical patients changed before and after the introduction of biological agents. Methods: Patients who underwent surgery for UC at Hyogo Medical University between 2000 and 2019 were included in the study; those who underwent surgery between 2000 and 2009 were included in the early group (n = 864), and those who underwent surgery between 2010 and 2019 were included in the late group (n = 834); each study factor was retrospectively compared. Results: The mean ages at surgery (y) were 39.7 ± 15.1 y in the early group and 46.7 ± 17.8 y in the late group ( Conclusion: The characteristics of UC patients requiring surgery in Japan have changed. The distribution of surgical indications changed, and the number of patients with cancer and dysplasia requiring surgery increased. The prognosis of elderly patients who underwent emergency surgery was poor.

Indexed as

biological agentmedical treatmentprognosissurgical treatmentulcerative colitis

Identifiers

PMID36998292
PMCPMC10043766
OpenAlexW4304203447

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read47
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.